These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3945245

  • 41. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G, Petrarulo M, Nardelotto A, Marangella M, Baggio B.
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [Abstract] [Full Text] [Related]

  • 42. Enteral nutrition and the risk of nephrolithiasis in complex pediatric patients.
    DeFoor W, Nehus E, Schulte M, Huesman S, Libs A, Niehaus R, Devarajan P.
    J Pediatr Urol; 2022 Dec; 18(6):743.e1-743.e6. PubMed ID: 35760671
    [Abstract] [Full Text] [Related]

  • 43. Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controls.
    Oehlschläger S, Fuessel S, Meye A, Herrmann J, Lotzkat U, Froehner M, Albrecht S, Wirth MP.
    Urology; 2011 Jan; 77(1):250.e1-5. PubMed ID: 20947140
    [Abstract] [Full Text] [Related]

  • 44. Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B, Marzaro G, Gambaro G, Marchini F, Williams HE, Borsatti A.
    Clin Sci (Lond); 1990 Aug; 79(2):113-6. PubMed ID: 2167799
    [Abstract] [Full Text] [Related]

  • 45. [Oxalate as a promoter in calcium oxalate nephrolithiasis].
    Yamakawa K, Katou T, Arima K, Yanagawa M, Kawamura J.
    Hinyokika Kiyo; 1991 Oct; 37(10):1111-4. PubMed ID: 1755400
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The impact of dietary oxalate on kidney stone formation.
    Holmes RP, Assimos DG.
    Urol Res; 2004 Oct; 32(5):311-6. PubMed ID: 15221245
    [Abstract] [Full Text] [Related]

  • 50. Familial idiopathic hypercalciuria.
    Coe FL, Parks JH, Moore ES.
    N Engl J Med; 1979 Feb 15; 300(7):337-40. PubMed ID: 759893
    [Abstract] [Full Text] [Related]

  • 51. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
    Baggio B, Gambaro G, Zambon S, Marchini F, Bassi A, Bordin L, Clari G, Manzato E.
    J Am Soc Nephrol; 1996 Apr 15; 7(4):613-20. PubMed ID: 8724896
    [Abstract] [Full Text] [Related]

  • 52. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM, Chen TW, Lee YH, Chu WY, Young TK.
    J Formos Med Assoc; 1990 Aug 15; 89(8):651-6. PubMed ID: 1981225
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.
    Monico CG, Weinstein A, Jiang Z, Rohlinger AL, Cogal AG, Bjornson BB, Olson JB, Bergstralh EJ, Milliner DS, Aronson PS.
    Am J Kidney Dis; 2008 Dec 15; 52(6):1096-103. PubMed ID: 18951670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.